449 results on '"Taylor-Cousar, Jennifer L."'
Search Results
2. Impact of Cystic Fibrosis Transmembrane Conductance Regulator Modulators on Maternal Outcomes During and After Pregnancy
3. Differential times of submission and approval of CFTR modulators for the treatment of Cystic Fibrosis in the United States and the European Union
4. Pregnancy and fertility in people with cystic fibrosis following lung transplantation
5. Association between CFTR modulators and changes in iron deficiency markers in cystic fibrosis
6. DNA sequencing analysis of cystic fibrosis transmembrane conductance regulator gene identifies cystic fibrosis-associated variants in the Severe Asthma Research Program.
7. Prioritizing sexual and reproductive health research and care for people with cystic fibrosis: A 2023 workshop report from the Cystic Fibrosis Foundation Sexual Health, Reproduction, and Gender (SHARING) Research Working Group
8. Standards for the care of people with cystic fibrosis (CF); Planning for a longer life
9. Clinician perspectives and practices related to sexual and reproductive care provision for males with cystic fibrosis
10. Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis
11. Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective
12. CFTR modulator therapy: transforming the landscape of clinical care in cystic fibrosis
13. Traits, trends and hits of orphan drug designations in cystic fibrosis
14. Association between unplanned pregnancies and maternal exacerbations in cystic fibrosis
15. Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials
16. Contributors
17. Orangutan Respiratory Disease Syndrome
18. Update on Clinical Outcomes of Highly Effective Modulator Therapy
19. The modern landscape of fertility, pregnancy, and parenthood in people with cystic fibrosis
20. Genetic therapies in cystic fibrosis
21. Parenthood impacts short-term health outcomes in people with cystic fibrosis
22. Pregnancy in cystic fibrosis: Review of the literature and expert recommendations
23. Olfactory dysfunction in cystic fibrosis: Impact of CFTR modulator therapy
24. Cardiovascular complications in cystic fibrosis: A review of the literature
25. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial
26. Fertility and Pregnancy in Cystic Fibrosis
27. Empire-CF study: A phase 2 clinical trial of leukotriene A4 hydrolase inhibitor acebilustat in adult subjects with cystic fibrosis
28. Riociguat for the treatment of Phe508del homozygous adults with cystic fibrosis
29. Challenges Faced by Women with Cystic Fibrosis
30. Challenges in the use of highly effective modulator treatment for cystic fibrosis
31. Maternal and fetal outcomes following elexacaftor-tezacaftor-ivacaftor use during pregnancy and lactation
32. Restarting Respiratory Clinical Research in the Era of the Coronavirus Disease 2019 Pandemic
33. Research Priorities in Pediatric Asthma Morbidity: Addressing the Impacts of Systemic Racism on Children with Asthma in the United States. An Official American Thoracic Society Workshop Report.
34. Disparities in elexacaftor/tezacaftor/ivacaftor initiation in the US cystic fibrosis population.
35. Impact of sinus surgery in people with cystic fibrosis and chronic rhinosinusitis in the era of highly effective modulator therapy: Protocol for a prospective observational study.
36. CLINICAL MANAGEMENT OF CHRONIC ORANGUTAN RESPIRATORY DISEASE SYNDROME IN THREE ADULT MALE BORNEAN ORANGUTANS (PONGO PYGMAEUS).
37. Outcomes of pregnancy in women with cystic fibrosis (CF) taking CFTR modulators – an international survey
38. Contraceptive use among women with cystic fibrosis: A pilot study linking reproductive health questions to the Cystic Fibrosis Foundation National Patient Registry
39. Impact of highly effective modulator therapy on chronic rhinosinusitis and health status: 2-year follow-up
40. Determining the minimal clinically important difference for the questionnaire of olfactory disorders in people with cystic fibrosis and factors associated with improvement after highly effective modulator therapy.
41. Chronic rhinosinusitis and olfaction after highly effective modulator therapy: The role of individual sinus inflammation
42. Determining the minimal clinically important difference for the questionnaire of olfactory disorders in people with cystic fibrosis and factors associated with improvement after highly effective modulator therapy
43. Compassionate use trials and equitable access to variant-specific treatment for cystic fibrosis
44. Olfactory loss in people with cystic fibrosis: Community perceptions and impact
45. Reflections 5 years on from the approval of ETI therapy
46. Triple combination cystic fibrosis transmembrane conductance regulator modulator therapy in the real world – opportunities and challenges
47. Lumacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease homozygous for F508del-CFTR
48. Decreases in Rhinology Care Utilization by People with Cystic Fibrosis on Highly Effective Modulator Therapy
49. Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in People With Cystic Fibrosis and at Least OneF508delAllele: 144-Week Interim Results From a 192-Week Open-label Extension Study
50. A provider survey assessing fetal impact of CFTR modulator use in males with CF during assisted and unassisted reproduction and partner pregnancy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.